Cynthia Levy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cynthia Levy has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Michaels
Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida, USA
2 shared publications Claudia O. Zein
Division of Gastroenterology and Hepatology, Case Western Reserve University, University Hospitals of Cleveland and Louis Stokes VA Medical Center, Cleveland, Ohio
1 shared publicationConsuelo Soldevila–Pico
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida
1 shared publicationDavid Nelson
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida
1 shared publicationGiuseppe Morelli
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida
1 shared publication- Ian L Steele
Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, USA
1 shared publication
Latest Publications
- 21 October 2008
- Vol. 10 (10) , 242
Endoscopic and surgical management of primary sclerosing cholangitis.
Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and extrahepatic bile ducts through inflammation and fibrosis. This development of inflammation and fibrosis leads to biliary complications including cirrhosis and ultimately death. Given the uncertainty surrounding the pathogenesis of the disease, many different medical therapies have been studied in the treatment of PSC. However, there currently are no effective medical therapies known to halt progression of disease. Additionally, patients with PSC often develop symptoms and complications that can be managed endoscopically or surgically. This review primarily focuses on endoscopic and surgical approaches that have been studied in the treatment of patients with PSC.
- 21 October 2008
- Vol. 10 (10) , 242
Endoscopic and surgical management of primary sclerosing cholangitis.
Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and extrahepatic bile ducts through inflammation and fibrosis. This development of inflammation and fibrosis leads to biliary complications including cirrhosis and ultimately death. Given the uncertainty surrounding the pathogenesis of the disease, many different medical therapies have been studied in the treatment of PSC. However, there currently are no effective medical therapies known to halt progression of disease. Additionally, patients with PSC often develop symptoms and complications that can be managed endoscopically or surgically. This review primarily focuses on endoscopic and surgical approaches that have been studied in the treatment of patients with PSC.
- 12 March 2008
- Vol. 10 (3) , 61
The medical management of primary sclerosing cholangitis.
Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and/or extrahepatic ducts through inflammation and fibrosis. This ultimately leads to biliary complications including cirrhosis, cholangiocarcinoma, and eventually death. Given the uncertainty surrounding the pathogenesis of the disease, a number of different medical therapies have been studied in the treatment of PSC. However, there currently are no effective medical therapies known to halt the progression of disease. The only definitive therapy for PSC is liver transplantation. This review will primarily focus on the medical approaches that have been studied for the treatment of PSC as well as on the management of symptoms commonly associated with the disease.
- 12 March 2008
- Vol. 10 (3) , 61
The medical management of primary sclerosing cholangitis.
Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and/or extrahepatic ducts through inflammation and fibrosis. This ultimately leads to biliary complications including cirrhosis, cholangiocarcinoma, and eventually death. Given the uncertainty surrounding the pathogenesis of the disease, a number of different medical therapies have been studied in the treatment of PSC. However, there currently are no effective medical therapies known to halt the progression of disease. The only definitive therapy for PSC is liver transplantation. This review will primarily focus on the medical approaches that have been studied for the treatment of PSC as well as on the management of symptoms commonly associated with the disease.
- 1 July 2007
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 5 (7) , 803-808
Prevalence and Predictors of Esophageal Varices in Patients With Primary Biliary Cirrhosis
- 1 July 2007
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 5 (7) , 803-808
Prevalence and Predictors of Esophageal Varices in Patients With Primary Biliary Cirrhosis